OS Therapies Incorporated (OSTX)

OS Therapies will go public soon, but the exact IPO date is still unknown.
IPO Price
$5.00
Shares Offered
2,000,000
Deal Size
$10.00M

Total Valuation

OS Therapies has a market cap or net worth of $126.03 million. The enterprise value is $137.43 million.

Market Cap 126.03M
Enterprise Value 137.43M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

OS Therapies has 25.21 million shares outstanding.

Shares Outstanding 25.21M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.53

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -1,228.56%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$2.13M
Employee Count 3
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (30 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -4.45M
Pretax Income -6.38M
Net Income -6.38M
EBITDA -3.42M
EBIT -4.57M
Earnings Per Share (EPS) -$0.25
Full Income Statement

Balance Sheet

The company has $171,480 in cash and $11.57 million in debt, giving a net cash position of -$11.40 million or -$0.45 per share.

Cash & Cash Equivalents 171,480
Total Debt 11.57M
Net Cash -11.40M
Net Cash Per Share -$0.45
Equity / Book Value -17.56M
Book Value Per Share -0.70
Working Capital -5.65M
Full Balance Sheet

Cash Flow

Operating Cash Flow -3.79M
Capital Expenditures n/a
Free Cash Flow -3.79M
FCF Per Share -$0.15
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OS Therapies does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -5.06%
FCF Yield -3.01%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1